Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2020-07-27 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
第二届董事会第十四次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of resolutions passed at the company's second board of directors' 14th meeting held on July 27, 2020. It includes voting results on several proposals such as approval of the 2020 semi-annual report and its summary, a special report on the use of raised funds, and a proposal on cash management of idle funds. The document states that the full semi-annual report is available on the designated disclosure website and that this announcement is published alongside other related disclosures. The document is short (1198 characters) and primarily serves to announce board meeting decisions and voting outcomes rather than containing the full semi-annual report or detailed financial data. Therefore, it is best classified as a Declaration of Voting Results & Voting Rights Announcement (DVA).
2020-07-27 Chinese
关于2020年半年度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (334 characters) indicating that the company's 2020 half-year report has been disclosed on the official stock exchange website. It does not contain the actual half-year financial report or substantive financial data, but rather a notice to investors to review the report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA).
2020-07-27 Chinese
2020年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2020 年半年度募集资金存放与使用情况的专项报告" which translates to "2020 Semi-Annual Special Report on the Deposit and Use of Raised Funds." It details the amount of funds raised, their usage, changes in investment projects, and compliance with regulatory requirements. The document includes detailed financial figures related to fundraising and usage for a half-year period (up to June 30, 2020). It is a comprehensive report on the use of capital raised by the company, including project changes and financial management of those funds. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is over 10,000 characters, so it is not a mere announcement of a report (RPA). It is not an annual or interim financial report, nor an earnings release or management discussion. It is a specialized report on fundraising and use of proceeds, fitting best under CAP.
2020-07-27 Chinese
2020年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 年半年度报告全文" which translates to "2020 Semi-Annual Report Full Text." It contains detailed financial data, business overview, risk factors, company profile, financial indicators, and operational analysis for the period from January 1, 2020 to June 30, 2020. The content includes comprehensive financial statements and management discussion and analysis typical of an interim or quarterly report. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-07-27 Chinese
2020年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2020年半年度报告摘要" which translates to "2020 Semi-Annual Report Summary." It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and other financial metrics compared to the previous year. It also discusses operational highlights, business strategy, R&D activities, shareholder information, and management commentary on the period's performance. The length of the document (7,521 characters) and the presence of substantive financial data and analysis confirm it is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-07-27 Chinese
关于使用部分闲置自有资金进行现金管理的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company regarding the use of idle funds for cash management, including details on investment purpose, types, limits, risk control measures, and approvals by the board and supervisory committee. It is a formal disclosure to shareholders and the market about a financial management decision, not a financial report or earnings release. The document is relatively short (2744 characters) and structured as a regulatory announcement about a corporate financial activity. It does not contain financial statements, audit opinions, or detailed financial results. Therefore, it fits best under the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-07-27 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.